Clinical Trial Update: Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study [Phase 3]

View source ↗

Summary

A Phase 3 trial (ARCHER) compares shorter-duration radiation therapy plus standard chemotherapy to standard radiation therapy with chemotherapy in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer
• Urothelial Carcinoma of the Bladder

Snippet

Sponsor: NRG Oncology | Conditions: Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | Phase 3 | Status: RECRUITING